Showing results (41-50 of 890) with videos related to
Sort By:
Pageof 89
Circulation Research|October 26, 2018
Established and Emerging Roles of Biomarkers in Heart FailureNasrien E Ibrahim, James L JanuzziClinics in Laboratory Medicine|February 11, 2014
Soluble ST2 and galectin-3 in heart failureRavi V Shah, James L JanuzziHeart Failure Clinics|March 28, 2022
Using Artificial Intelligence to Better Predict and Develop BiomarkersSam A Michelhaugh, James L JanuzziBMC Oral Health|May 13, 2022
Changes in salivary matrix metalloproteinase-3, -8, and -9 concentrations after 6 weeks of non-surgical periodontal therapyHan-Na KimThe American Journal of Cardiology|February 11, 2015
The biology of ST2: the International ST2 Consensus PanelDomingo A Pascual-Figal, James L JanuzziDiabetes, Obesity & Metabolism|April 4, 2020
Management of heart failure and type 2 diabetes mellitus: Maximizing complementary drug therapyJaved Butler, James L Januzzi, Julio RosenstockReviews in Cardiovascular Medicine|August 8, 2025
Cardiovascular-Kidney-Metabolic Effects: Steroidal and Nonsteroidal Mineralocorticoid Receptor AntagonistsBiykem Bozkurt, James L Januzzi, Shweta BansalClinical Chemistry|November 17, 2011
Emerging biomarkers in heart failureRoland R J van Kimmenade, James L JanuzziClinical Cardiology|June 24, 2005
Peripheral arterial disease, acute coronary syndromes, and early invasive management: the TACTICS TIMI 18 trialJames L Januzzi, Jacqueline Buros, Christopher P Cannon, et al.The American Journal of Cardiology|February 11, 2015
ST2 and prognosis in acutely decompensated heart failure: the International ST2 Consensus PanelJames L Januzzi, Alexandre Mebazaa, Salvatore Di SommaPageof 89